Eco R1 Capital, LLC Apellis Pharmaceuticals, Inc. Transaction History
Eco R1 Capital, LLC
- $1.27 Billion
- Q1 2025
A detailed history of Eco R1 Capital, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 11,895,808 shares of APLS stock, worth $282 Million. This represents 20.45% of its overall portfolio holdings.
Number of Shares
11,895,808
Previous 11,890,843
0.04%
Holding current value
$282 Million
Previous $379 Million
31.43%
% of portfolio
20.45%
Previous 17.73%
Shares
12 transactions
Others Institutions Holding APLS
# of Institutions
286Shares Held
125MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$292 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$290 Million4.32% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$240 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$228 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$138 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.61B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...